$MACK Headlines Stock futures rise on Bernanke rate

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
$MACK Headlines

Stock futures rise on Bernanke rate comments 5:46 p.m. July 10, 2013 - Wallace Witkowski
Merrimack to offer $50 mln in stock, $75 mln notes 5:24 p.m. July 10, 2013 - MarketWatch.com
Stocks to watch Friday: Goldman, Bally, Scotts 6:54 a.m. Aug. 10, 2012 - MarketWatch
IPO scorecard: Update on selected offering 2:18 p.m. June 8, 2012 - Dow Jones
Shares of Merrimack Pharmaceuticals off post IPO 3:19 a.m. March 30, 2012 - MarketWatch.com

Market Has Not Yet Noticed Potential in Merrimack Pharmaceuticals (MACK); Have You? - Tale of the Tape 8:39 a.m. Sept. 10, 2014 - Zacks.com
Can Merrimack Pharmaceuticals (MACK) Run Higher on Strong Earnings Estimate Revisions? - Tale of the Tape 8:43 a.m. Sept. 9, 2014 - Zacks.com
Will Merrimack Pharmaceuticals (MACK) Crush Estimates at Its Next Earnings Report? - Tale of the Tape 8:54 a.m. Aug. 20, 2014 - Zacks.com
10-Q: MERRIMACK PHARMACEUTICALS INC 4:06 p.m. Aug. 11, 2014 - Edgar Online - (EDG = 10Q, 10K)
Merrimack Pharmaceuticals' (MACK) CEO Bob Mulroy on Q2 2014 Results - Earnings Call Transcript 3:01 p.m. Aug. 11, 2014 - Seeking Alpha
Update: Merrimack Earnings - Looming Concerns Still Remain 2:04 p.m. Aug. 11, 2014 - Seeking Alpha
More on Merrimack Pharma Q2 results 8:02 a.m. Aug. 11, 2014 - Seeking Alpha
Is Now The Time To Buy Merrimack Pharmaceuticals? 11:17 a.m. July 8, 2014 - Seeking Alpha
They're the Millers: Two Best Funds in Winners' Circle Contest 4:47 p.m. July 6, 2014 - The Wall Street Journal Interactive Edition
Insider Trading Alert - MACK, POOL And GPS Traded By Insiders 1:30 p.m. June 25, 2014 - TheStreet.com
InsiderInsights.com Daily Round Up: 6/24/14 8:37 a.m. June 25, 2014 - Seeking Alpha
Merrimack Falls Steeply as Sanofi Returns Oncology Drug Rights - Analyst Blog 4:45 p.m. June 23, 2014 - Zacks.com
Merrimack Pharmaceuticals (MACK) Crumbles: Stock Tanks by 11.3% - Tale of the Tape 8:33 a.m. June 23, 2014 - Zacks.com
Merrimack Pharmaceuticals: The Sleeping Giant Of Cancer Care 11:38 a.m. June 20, 2014 - Seeking Alpha
Sanofi pulls the plug on Merrimack mAb for cancer 8:35 a.m. June 20, 2014 - Seeking Alpha
Why Merrimack Pharmaceuticals (MACK) Stock is Down in After-Hours Trading Today 4:47 p.m. June 19, 2014 - TheStreet.com
Merrimack Pharmaceuticals: Setting The Record Straight On MM 398 12:01 p.m. May 16, 2014 - Seeking Alpha
Merrimack Pharma and the Marginal Benefit of Pancreatic Cancer Drug MM-398 7:00 a.m. May 14, 2014 - TheStreet.com
Biotech Stock Mailbag: Sarepta, F-R Rule Stock Predictions, Merrimack 6:00 a.m. May 9, 2014 - TheStreet.com
Jim Cramer's 'Mad Money' Recap: Bubbles vs. Valuation 8:22 p.m. May 8, 2014 - TheStreet.com


Merrimack Pharmaceuticals to Present Clinical and Biomarker Data on Novel Antibody Therapeutics at the ESMO 2014 Congress 8:00 a.m. Sept. 19, 2014 - GlobeNewswire
Merrimack Pharmaceuticals Announces Initiation of HERMIONE, a Randomized Trial of MM-302 in Patients With Advanced HER2-Positive Breast Cancer to Support Application for Accelerated Approval 7:06 a.m. Aug. 11, 2014 - GlobeNewswire
Merrimack Pharmaceuticals Reports Second Quarter 2014 Financial Results 7:01 a.m. Aug. 11, 2014 - GlobeNewswire
Biotech Equities Technical Analysis -- BioMarin Pharma, Merrimack Pharma, Sangamo BioSciences, ZIOPHARM Oncology, and Dyax 8:50 a.m. Aug. 7, 2014 - PR Newswire - PRF
Merrimack Pharmaceuticals Announces Timing of Second Quarter 2014 Investor Conference Call 4:02 p.m. Aug. 4, 2014 - GlobeNewswire
Divestitures, Agreement for Developmental Rights, Data Presentations, Technical Update, and Licensing Agreements - Analyst Notes on Akorn, Merrimack, Avanir, Omeros and TG Therapeutics 6:40 a.m. June 27, 2014 - PR Newswire - PRF
Merrimack Pharmaceuticals Presents Data From Phase 3 NAPOLI-1 Study at the ESMO 16th World Congress on Gastrointestinal Cancer 4:05 p.m. June 25, 2014 - GlobeNewswire
Biotech R&D and Clinical Trials Lead To Potential Revenue Growth - Company's Data of Phase l & Phase ll For HCC Patients Highly Suggestive of Positive Clinical Activity 8:15 a.m. June 25, 2014 - PR Newswire - PRF
Merrimack Pharmaceuticals to Regain Worldwide Rights to Develop and Commercialize MM-121 4:15 p.m. June 19, 2014 - GlobeNewswire
Merrimack Pharmaceuticals Announces Oral Presentation of Additional Data Results in Phase 3 NAPOLI-1 Study at the ESMO 16th World Congress on Gastrointestinal Cancer 8:01 a.m. June 17, 2014 - GlobeNewswire
Battle of the Biotech Bands - A Great Time for a Great Cause 2:45 p.m. June 12, 2014 - PR Newswire - PRF
Merrimack Pharmaceuticals Presents Phase 1 Clinical Data Supporting Four Novel Antibody Therapeutic Programs at the 2014 ASCO Annual Meeting 4:00 p.m. June 2, 2014 - GlobeNewswire
Merrimack Pharmaceuticals Identifies Heregulin as Patient Response Biomarker for MM-121 and Standard of Care Therapy Across Multiple Cancers 9:36 a.m. June 2, 2014 - GlobeNewswire
Fundraising Support, Upcoming Conferences, Clinical Data Presentations, and Cash Dividends - Analyst Notes on WellCare, NPS Pharma, Merrimack Pharmaceuticals, CONMED and Haemonetics 8:00 a.m. May 28, 2014 - PR Newswire - PRF
Equities Marking a New High -- Research on JD.com, NRG Energy, Merrimack Pharma and Arris Group 5:40 a.m. May 28, 2014 - PR Newswire - PRF
Merrimack Pharmaceuticals to Present at the Jefferies 2014 Global Healthcare Conference 8:01 a.m. May 27, 2014 - GlobeNewswire
Merrimack Pharmaceuticals to Present Clinical Data Across Oncology Pipeline at ASCO 2014 5:25 p.m. May 22, 2014 - GlobeNewswire
Merrimack Pharmaceuticals to Present at the Bank of America Merrill Lynch 2014 Health Care Conference 4:03 p.m. May 7, 2014 - GlobeNewswire
Nuvilex's Pancreatic Cancer Treatment Continues to Outperform Big Pharma Heading Into Late Phase Trials 9:04 a.m. May 7, 2014 - Marketwire
Biotech Stocks Review -- Research on Retrophin, Merrimack, Gilead Sciences, and Rexahn Pharma 12:37 p.m. May 6, 2014 - PR Newswire - PRF

Scroll down for more posts ▼

Top 10 Most Recent News Articles

AllyGPO Shines as Top Innovator in Health Tech

Updated Category News Views 2

Innovative Excellence in Healthcare Tech It's not every day you see a specialty group purchasing organization like AllyGPO snagging a spot on Fast Company's esteemed list of Best Workplaces for Innovators. Making it into the top half at number 40 in 2026, it’s a testament to a company really leaning into employee-driven innovation. And, buddy, this ain't just corporate...

Continue Reading
Nashville Benefit Concert Supports Animal Rescue Mission

Updated Category News Views 1

Country Tunes and Compassion Unite for Rescue Efforts There's something electric about a community banding together, especially when it's through the warmth of country music and the noble mission of animal rescue. Animal Rescue Corps (ARC), meeting ground for art and heart, is turning the Nashville Palace into a sanctuary not just for music, but for hope. They've got...

Continue Reading
MADD, Uber Rally at Capital Invitational for Safe Choices

Updated Category News Views 2

Driving Change at the Capital Invitational Let's talk about a powerhouse collaboration aiming to do more than just thrill basketball fans. We're looking at MADD Sports, Uber, and the Capital Invitational joining forces at The St. James in Springfield, Virginia, on December 10, 2026. This is not your average sporting event; it's a gathering with a bigger purpose. The...

Continue Reading
India's First Upright Proton Therapy System Unveiled

Updated Category News Views 3

A Leap Forward in Cancer Care: Proton Therapy Revolution Dang, just when you think you've heard it all in cancer treatment, Fortis Healthcare drops a bombshell: India’s first upright proton therapy system. Boom! This isn't your run-of-the-mill radiation treatment we're talking about here. This is the futuristic flair of the MEVION S250-FIT™, featuring upright...

Continue Reading
West Texas Weather Shapes Home Design Decisions

Updated Category News Views 2

West Texas Weather: A Tough Customer for Home Builders You'd think building a house is a straightforward gig, but slap it down in West Texas, and we're talking a whole different ballgame. With its brutal heat, howling winds, and wild temperature swings, Odessa isn't just painting by numbers. It's where Mother Nature is your uninvited consultant on every single...

Continue Reading
1M+ California Homes Face Extreme Wildfire Risk Revealed

Updated Category News Views 2

Wildfire Risk in California: A Growing Alarm If there's one thing that's become a bitter truth over the years, it's that California and wildfires are inseparably linked, like mayo on a greasy diner BLT—except way worse for the gut. The latest round of data from Guidewire HazardHub is practically sounding the alarm bells louder than ever. Over a million homes in...

Continue Reading
Verdafero Gains Ground in Sustainable Hospitality

Updated Category News Views 1

Verdafero's Latest Milestone: A Broader Environmental Reach It’s a day like today that makes you pause and realize that businesses in the hospitality space aren’t just about fluff and fancy lobbies anymore. They've got a new wave of responsibilities, especially with the globe pretty much on fire, literally and figuratively. Verdafero, a name not new to function and...

Continue Reading
BrightPlan's AI-Powered Growth: Series C Fuel

Updated Category News Views 2

Series C Funding Ignites BrightPlan's Ambitions Ever seen a company that's ready to roll with the punches and come out stronger? That's BrightPlan for you. They're pushing the boundaries again, bagging new capital in this Series C round, steered by the seasoned folks over at ABS Capital Partners. Now, here's the thing: We're talking about a 230% revenue surge over just...

Continue Reading
Innventure Faces Major Lawsuit Amidst Market Turmoil

Updated Category News Views 0

The Plot Thickens with Innventure's DarkNX Project Buckle up, fellow market sling-riders; the Innventure tale is a rocky one for the books. Imagine this: You’ve plunked down your hard-earned cash on Innventure Inc. (NASDAQ: INV), lured by their glowing pronouncements about a supposed golden egg project, the Accelsius DarkNX data-center deal. A big talk about...

Continue Reading
Tiger Group to Auction Huge Window Manufacturing Plant

Updated Category News Views 1

Glass & Vinyl Ambitions: A New Chapter Who would have guessed? The seasoned window maker Showcase Window and Door Company is putting its prime manufacturing facility up for grabs. The online auction, orchestrated by Tiger Group, kicks off September 10, and it's sure to stir up some excitement in the industry. With picking up operations now within reach, it feels like...

Continue Reading

Top 5 Most Recently Viewed Articles

Palomar Holdings Set for Release of Q3 2024 Financial Results

Updated Category News Views 214

Palomar Holdings Announces Financial Results Release Palomar Holdings, Inc. (NASDAQ: PLMR) has recently made an exciting announcement regarding its upcoming financial results. The company will release its financial results for the third quarter of 2024 after the market closes on a specified date, which is the forthcoming Monday. This is a crucial moment for investors and...

Continue Reading
Wall Street Trends: Insights on High-Performing Stocks

Updated Category News Views 453

Wall Street Experiences a Retreat from Record Highs This week, Wall Street showed signs of a retreat from its record highs. Key influences included cautious profit outlooks from major companies and economic concerns highlighted by the Federal Reserve. The recent forecast from a leading retail giant raised flags about consumer spending amid uncertainty caused by inflation...

Continue Reading
Elevai Labs Reports Positive Clinical Study Results

Updated Category News Views 109

Elevai Labs Inc. Shares Promising Clinical Study Results Elevai Labs, Inc. (NASDAQ: ELAB), a leader in the field of medical aesthetics, has announced the successful completion of a clinical study that evaluated the effectiveness of Elevai exosomes on facial appearance. The internal review of the study's data shows that Elevai enfinity™ is both safe and well-tolerated,...

Continue Reading
Barratt Developments Sees Profits Fall Amid Market Challenges

Updated Category News Views 77

Barratt Developments Sees Decline in Profits Shares of Barratt Developments (LON:BDEV) have recently fallen after the company reported a significant drop in profits for the year ending in June. This decline comes as the housing sector grapples with a challenging market environment. Financial Summary In the latest trading update, Barratt's shares were down by 1.8%, trading...

Continue Reading
Analysts Boost Expectations for American Healthcare REIT Stock

Updated Category News Views 149

KeyBanc Raises Price Target for American Healthcare REIT Recently, KeyBanc Capital Markets increased its price target for American Healthcare REIT, Inc (NYSE: AHR) to $28, up from $27, while keeping an Overweight rating on the stock. This change comes after the company announced a larger follow-on common equity offering aimed at acquiring the remaining interest in Trilogy...

Continue Reading